Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Feb 2025 for Singular Genomics Systems, Inc.. Read the official filing
Filing timeline
BuySaleDavid l. Barker
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+59.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
David l. Barker: trading record in brief
David l. Barker (board member) discloses dealings in 2 companies, chiefly Bionano Genomics, Inc. and Singular Genomics Systems, Inc. We count 4 filings; the first trade dates from 16 May 2022 and the latest from 21 February 2025.
Every open-market trade on record is a purchase: 1 purchase worth €15k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.
Most recently, on 25 February 2025, the filings show a transaction in Singular Genomics Systems, Inc. The clock since the last published purchase (18 May 2022) now reads 1,614 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David l. Barker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
60,000 sharesCommon StockSEC:0000950170-25-027089:0
44,470 shares@ US$0.5159.3% of flowCommon StockSEC:0001411690-22-000016:0
60,000 shares@ US$0.63100.0% of flowCommon StockSEC:0001209191-22-041844:0
10,000 shares@ US$1.6040.7% of flowCommon StockSEC:0001209191-22-030026:0
Canonical exit: 14 Aug 2022 (T+90)
4 of 4 declarations
